Jak2 Positive Myeloproliferative Neoplasm Treatment
JAK2 positive myeloproliferative neoplasms (MPNs) represent a group of blood disorders characterized by the overproduction of blood cells due to mutations in the Janus kinase 2 (JAK2) gene. These disorders include polycythemia vera, essential thrombocythemia, and primary myelofibrosis. The presence of the JAK2 mutation plays a crucial role in the disease’s development and progression, making … Read more